eu convalescent plasma platform
TRANSCRIPT
11
EU Convalescent Plasma Platform Stéphane Bégué, European Blood AllianceOrsi Nagy, DG SANTE
2
The context A promising treatment
Starting the EU cooperation The Project team
DG SANTE B4 – policy
DG DIGIT D1 – technical aspects
European Blood alliance (NGO) – technical input on plasma / direct engagement with blood establishments
DG SANTE 02 and A1 - web and GDPR
DG CNECT – infrastructure (BDTI)
1. Strong existing cooperation of EU, ECDC, National Competent Authorities and Blood Establishments
2. Guidance document on the collection and transfusion of convalescent COVID-19 plasma to the donation, collection, testing, processing, storage, distribution and monitoring of convalescent plasma
3. Need for an European Open Database to collect practices and experience from European countries regarding CCP collection and use
3
Open-access database to gather data from monitored use of convalescent plasma, as well as from randomisedclinical trials
Aim: consolidate EU evidence on the safety and effectiveness of this promising therapy
Input: all EU/EEA blood establishments that wish to participate, via the EBA.
Go live: data collection module: April –continuous improvements. Last addition: dashboards
5
6
`
7
8
9
https://ec.europa.eu/health/blood_tissues_organs/covid-19_enhttps://www.euccp.dataplatform.tech.ec.europa.eu/
10
Click to edit Master title style
11
Click to edit Master title style